Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01766232 · ClinicalTrials.gov registry record

Lacrimal Drainage Resistance Study

A clinical trial, sponsored by The Cleveland Clinic.

Completed
Registry status
40
Enrollment target

NCT01766232: Completed study, sponsored by The Cleveland Clinic.

NCT01766232 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01766232 has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
40 participants
Enrollment target

Study Summary

Epiphora, or uncontrolled tearing of the eyes, represents a common presenting complaint of patients seen by ophthalmologists. Epiphora may be due to non-obstructive causes, such as tear hypersecretion or functional tear pump failure, or obstructive causes. Functional tear pump failure may result from malposition of the eyelids, such as an abnormal out-turning (ectropion) or in-turning (entropion) of the eyelid. Currently methods to diagnose partial nasolacrimal duct obstruction are purely qualitative in nature. Our research goal is to quantitatively measure the pressure generated during conventional probing and irrigation (P\&I), and to measure the resistance to irrigation of the nasolacrimal drainage system. The investigators will measure the pressure generated during conventional P\&I using a disposable in-line pressure transducer. In addition, the investigators will use a syringe pump to deliver a constant flow rate of saline through a nasolacrimal cannula and measure the steady state irrigation pressure using the in-line transducer and digital pressure monitor. Resistance can be directly calculated from the known flow rate and pressure measurements. The investigators will compare both the pressure generated during P\&I and the lacrimal drainage resistance between patients with lacrimal drainage obstruction and controls patients with no obstruction (functional tear pump failure) as determined by clinical exam. Clinical applications for measuring lacrimal drainage resistance include quantifying partial nasolacrimal duct obstruction, guiding the choice of surgical procedure, and determining the success of lacrimal drainage procedures.

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2009-04
Est. Completion 2015-02
The Cleveland Clinic

688 total trials

What the finished NCT01766232 record still lists

NCT01766232 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01766232 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01766232 about?

NCT01766232 is a clinical study titled "Lacrimal Drainage Resistance Study". Epiphora, or uncontrolled tearing of the eyes, represents a common presenting complaint of patients seen by ophthalmologists. Epiphora may be due to non-obstructive causes, such as tear hypersecretion or functional tear pump failure, or obstructive causes. Functional tear pump failure may result fro...

What is the current status of trial NCT01766232?

This trial is currently completed. The enrollment target is 40 participants. The study started on 2009-04. Estimated completion is 2015-02.

Who is sponsoring clinical trial NCT01766232?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01766232, the US trial registry maintained by the National Library of Medicine. NCT01766232 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.